Shreyas P. Vaidya - Publications
Affiliations: | Tata Institute of Fundamental Research, Mumbai, Maharashtra, India |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | M M, Chhatar S, Gadre S, Paul S, Vaidya SP, Khatri S, Duari P, Kode J, Ingle A, Kolthur-Seetharam U, Patra M. Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability. Chemistry (Weinheim An Der Bergstrasse, Germany). e202302720. PMID 37888749 DOI: 10.1002/chem.202302720 | 0.566 | |||
2023 | Panda TR, Manikandan M, Vaidya SP, Chhatar S, Sinha S, Mehrotra M, Chakraborty S, Gadre S, Duari P, Ray P, Patra M. The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity. Angewandte Chemie (International Ed. in English). e202303958. PMID 37314332 DOI: 10.1002/anie.202303958 | 0.601 | |||
2022 | Vaidya SP, Patra M. Platinum glycoconjugates: "Sweet bullets" for targeted cancer therapy? Current Opinion in Chemical Biology. 72: 102236. PMID 36516491 DOI: 10.1016/j.cbpa.2022.102236 | 0.633 | |||
2022 | Vaidya SP, Gadre S, Teja KR, Patra M. Challenges and opportunities in the development of metal-based anticancer theranostic agents. Bioscience Reports. PMID 35420649 DOI: 10.1042/BSR20212160 | 0.583 | |||
2021 | Patra M, Vaidya SP. X-rays actuate anticancer drugs: Opening new vistas in prodrug therapy. Chembiochem : a European Journal of Chemical Biology. PMID 34406685 DOI: 10.1002/cbic.202100373 | 0.542 | |||
Show low-probability matches. |